Vivani Medical, Inc.
VANI Nasdaq· Electromedical & Electrotherapeutic Apparatus
Last close · Oct 27, 2026
$1.14
KIRA · Stoqly’s AI analyst, in plain words
- Vivani Medical, Inc. had $0.0M of revenue in fiscal 2025.
- Vivani Medical, Inc. lost $26.6M in fiscal 2025.
- Free cash flow was −$25.5M in fiscal 2025, — of revenue.
Market cap
$99.3M
P/E
—
Revenue
$0.0M
Net income
−$26.6M
Free cash flow
−$25.5M
Operating margin
—
Vivani Medical, Inc. in 30 seconds · fiscal 2025
Does it make a profit?
−$26.6M
No. It lost money last year.
How healthy are the accounts?
1 / 7
Weak. It passes 1 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Vivani Medical, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 26, 2026
- Legal name
- Vivani Medical, Inc.
- CIK
- 0001266806
Vivani Medical, Inc. · VANI
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | — | — | — | $0.0M | $0.0M |
| Net income | −$12.8M | −$13.9M | −$25.7M | −$23.5M | −$26.6M |
| Diluted EPS | −$0.27 | — | −$0.50 | −$0.43 | −$0.43 |
| Cash | |||||
| Cash from operations | −$11.0M | −$18.8M | −$23.7M | −$20.8M | −$24.3M |
| Capital expenditure | $0.6M | $0.3M | $0.9M | $0.6M | $1.2M |
| Free cash flow | −$11.5M | −$19.1M | −$24.6M | −$21.3M | −$25.5M |
| Share count change | 59.5% | — | — | 107,917.7% | 13.5% |
| Debt and strength | |||||
| Cash and short-term investments | $2.2M | $45.1M | $20.7M | $18.4M | $16.2M |
| Shareholders' equity | $2.5M | $44.3M | $20.8M | $17.6M | $15.7M |
| Current ratio | 1.2x | 7.0x | 4.0x | 3.4x | 2.7x |
| Returns and quality | |||||
| Return on equity | −578.6% | −59.4% | −78.8% | −122.4% | −159.6% |
| Return on tangible equity | −518.2% | −31.3% | −123.6% | −133.4% | −169.2% |
| Piotroski F-score | — | — | — | — | 1 |
| Altman Z'' | −50.3 | 4.6 | −7.6 | −10.5 | −14.4 |
Insiders bought, 12 months
$18.6M
2 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Vivani Medical, Inc. · VANI
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.14 a share, the company is worth $99.3M.
Source: SEC EDGAR XBRL filings (CIK 0001266806). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.